What is Compulsory Licensing and How Does it Affect Cancer Drugs?
Compulsory licensing is a mechanism that allows a government to permit a third party to produce a patented product without the consent of the patent owner, typically in situations of public health emergencies. In the case of cancer drugs, compulsory licensing can be used to make essential medications more accessible, especially in countries where the cost of patented drugs is prohibitive.
